Rare diseases
Investigational molecules
Locations
Back to Czechia37 clinical trials in Liberec, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
CzechiaStudy of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis
CzechiaStudy of dapagliflozin effects in patients hospitalized with acute heart failure
CzechiaStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
CzechiaStudy on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment
CzechiaStudy on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure
CzechiaStudy on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection
CzechiaStudy on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists
CzechiaStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Multiple innovative trials focusing on non-small cell lung cancer and advanced prostate cancer treatments, evaluating novel therapeutic combinations and targeted approaches.
Studies are investigating breakthrough treatments including immunotherapy combinations and hormone therapy optimizations.
Extensive research into cardiovascular diseases, including studies on stroke prevention, atrial fibrillation, and innovative treatments for heart failure.
Investigations focus on both preventive measures and therapeutic interventions for various cardiac conditions.
Groundbreaking research in liver diseases, particularly focusing on non-alcoholic steatohepatitis (NASH) and cirrhosis treatments.
Novel combination therapies and innovative treatment strategies are being evaluated for liver conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
